hVIVO (LON:HVO) Shares Down 6.8% – Here’s What Happened

hVIVO plc (LON:HVO)’s stock price was down 6.8% during mid-day trading on Thursday . The company traded as low as GBX 19 ($0.24) and last traded at GBX 19.10 ($0.24). Approximately 2,268,262 shares changed hands during mid-day trading, a decline of 33% from the average daily volume of 3,389,765 shares. The stock had previously closed at GBX 20.50 ($0.26).

hVIVO Price Performance

The company has a 50 day moving average of GBX 23.58 and a 200 day moving average of GBX 26.77. The company has a debt-to-equity ratio of 33.86, a quick ratio of 1.16 and a current ratio of 1.61. The stock has a market capitalization of £129.95 million, a price-to-earnings ratio of 636.67 and a beta of 0.97.

About hVIVO

hVIVO plc operates as a pharmaceutical service and contract research company. The company is involved in testing vaccines and antivirals using human challenge clinical trials. It provides services to big pharma, biotech, government, and public health organizations. The company has a portfolio of human challenge study models for conditions, such as RSV, flu, human rhinovirus, asthma, malaria, cough, and COPD, as well as developing COVID-19 human challenge study model.